NVO Dividend Calculator
Novo Nordisk A/S yields 4.63%, comfortably above the 2.92% median across US dividend payers. That puts NVO in the range where the income is the main reason to hold it, and where the durability of the payment does most of the work in any long-run figure.
NVO paid $1.80 per share over the last twelve months on a semi-annual schedule. Enter any amount below, or use the worked figures.
Your investment
NVO
Novo Nordisk A/S
4.63%
yield
Dividend income
$10,000 in NVO pays you
$462.88
per year
- Paid twice a year
- $231.44
- Monthly average
- $38.57
- Shares bought
- 257.73
- Payments a year
- 2
Total over 10 years, taken as cash
$4,628.76
Based on the trailing twelve-month dividend, assuming it stays flat. Payments are not guaranteed and can be cut or suspended at any time. Figures are before tax and exclude any change in the share price.
NVO dividend income by investment amount
Based on the current yield of 4.63%. Figures are before tax and assume the dividend stays at its present level.
| Invested | Per year | Per payment | Monthly average |
|---|---|---|---|
| $1,000 | $46.29 | $23.14 | $3.86 |
| $5,000 | $231.44 | $115.72 | $19.29 |
| $10,000 | $462.88 | $231.44 | $38.57 |
| $25,000 | $1,157.19 | $578.60 | $96.43 |
| $50,000 | $2,314.38 | $1,157.19 | $192.87 |
| $100,000 | $4,628.76 | $2,314.38 | $385.73 |
NVO with dividends reinvested
$10,000 in NVO, every dividend reinvested, holding the payment and share price flat. Deliberately conservative — most calculators assume years of uninterrupted growth, and that assumption drives most of the result.
- After 10 years
- $15,803
- After 20 years
- $24,973
- After 30 years
- $39,464
$14,629 taking the income as cash
$19,258 taking the income as cash
$23,886 taking the income as cash
What makes up NVO's 4.63% yield
NVO paid $1.80 per share over the last twelve months against a share price of $38.80, which is where the 4.63% comes from. Special and one-off distributions are excluded from that figure — they do not recur, and including them would overstate every projection below.
Yields at this level usually have a structural explanation rather than a mispricing: the company is organised to distribute income rather than retain it. Worth checking how NVO's current yield compares with its own history, since a sharp recent rise more often reflects a falling price than a raised payment.
Healthcare dividends compete for the same cash as research spending, which is why yields in the sector are typically modest even at large companies. The sector-specific risk to the payment is patent expiry: revenue concentrated in one or two products can step down sharply rather than decline gradually.
When NVO pays, and what that changes
NVO pays semi-annual, which is unusual among US-listed payers and has two consequences the annual figure hides. The "monthly average" column is an average and nothing more — no cash arrives in most months — and the gap between payments means a holder buying between them waits longer for the first one.
Infrequent payments also compound marginally more slowly when reinvested, since each distribution spends longer as cash before it is put back to work. The reinvestment figures above use NVO's real schedule rather than assuming quarterly payments.
Each payment has an ex-dividend date, and it is the date that governs entitlement: shares bought on or after it do not carry that payment. NVO's full schedule and payment history are on its dividend page.
Is NVO's dividend covered by earnings?
NVO's payout ratio of 0.45 means roughly 45% of earnings go to the dividend, leaving the rest retained. A margin that size is what allows a payment to be maintained through a weaker year without being funded from borrowing.
Demand in this kind of business holds up across a cycle, so the earnings behind the ratio move less than the market's average and the figure is reasonably representative rather than a snapshot of a good year.
The figures hold the dividend flat. NVO has raised its payment in each of the last 6 years, which is a shorter record than the multi-decade streaks found among the longest-standing payers, and not yet long enough to have been tested across a full cycle.
NVO dividend calculator FAQ
- How much does $10,000 in NVO pay in dividends?
- At NVO's current yield of 4.63%, $10,000 pays about $462.88 a year — roughly $231.44 per payment, paid semi-annual, or $38.57 a month averaged out.
- What would NVO be worth after 10 years with dividends reinvested?
- Reinvesting every dividend and assuming the payment and share price both stay flat, $10,000 in NVO would grow to about $15,803 after 10 years, against $14,629 if the income were taken as cash. That deliberately assumes no dividend growth — a real holding may do better or considerably worse.
- How often does NVO pay dividends?
- NVO pays semi-annual — 2 payments a year — based on its actual payment history rather than an assumed schedule.
- Is NVO's dividend guaranteed?
- No. Dividends are discretionary and can be reduced or suspended at any time, and every figure here is a projection from the current yield rather than a forecast. Check NVO's full payment history before relying on any of it.
- Why is NVO's dividend yield so high?
- NVO yields 4.63% against a 2.92% median across US dividend payers. A yield is a ratio, so it rises either because the payment went up or because the share price came down — and the figure alone does not say which. Yields this far above the market among ordinary operating companies are unusual and often reflect what the market expects rather than what has been announced.
More on NVO
Novo Nordisk A/S is a common stock trading at $38.80 per share, paying semi-annual. — All figures before tax. Not financial advice.